Abstract
The highlight of the 2008 Conference on Retroviruses and Opportunistic Infections was a sober assessment of the HIV vaccine field by one of its pioneers. Desrosiers delivered a plenary session in which he called for refocusing our HIV vaccine effort. He suggested that none of the current vaccine candidates in human clinical trials stands a chance against HIV. Thus, we need to redirect our efforts to basic vaccine research. This call for a sea change in how we carry out HIV vaccine research has already had an impact, prompting a recent HIV vaccine summit in Bethesda, MD. This will likely herald a new era in HIV vaccine research, resulting in a redoubling of effort to uncover innovative new ways of making an HIV vaccine.
| Original language | English |
|---|---|
| Pages (from-to) | 7-8 |
| Number of pages | 2 |
| Journal | Topics in HIV medicine : a publication of the International AIDS Society, USA |
| Volume | 16 |
| Issue number | 1 |
| State | Published - Apr 1 2008 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Basic HIV vaccine development. / Watkins, David.
In: Topics in HIV medicine : a publication of the International AIDS Society, USA, Vol. 16, No. 1, 01.04.2008, p. 7-8.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Basic HIV vaccine development.
AU - Watkins, David
PY - 2008/4/1
Y1 - 2008/4/1
N2 - The highlight of the 2008 Conference on Retroviruses and Opportunistic Infections was a sober assessment of the HIV vaccine field by one of its pioneers. Desrosiers delivered a plenary session in which he called for refocusing our HIV vaccine effort. He suggested that none of the current vaccine candidates in human clinical trials stands a chance against HIV. Thus, we need to redirect our efforts to basic vaccine research. This call for a sea change in how we carry out HIV vaccine research has already had an impact, prompting a recent HIV vaccine summit in Bethesda, MD. This will likely herald a new era in HIV vaccine research, resulting in a redoubling of effort to uncover innovative new ways of making an HIV vaccine.
AB - The highlight of the 2008 Conference on Retroviruses and Opportunistic Infections was a sober assessment of the HIV vaccine field by one of its pioneers. Desrosiers delivered a plenary session in which he called for refocusing our HIV vaccine effort. He suggested that none of the current vaccine candidates in human clinical trials stands a chance against HIV. Thus, we need to redirect our efforts to basic vaccine research. This call for a sea change in how we carry out HIV vaccine research has already had an impact, prompting a recent HIV vaccine summit in Bethesda, MD. This will likely herald a new era in HIV vaccine research, resulting in a redoubling of effort to uncover innovative new ways of making an HIV vaccine.
UR - http://www.scopus.com/inward/record.url?scp=54049091269&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=54049091269&partnerID=8YFLogxK
M3 - Article
C2 - 18441377
AN - SCOPUS:54049091269
VL - 16
SP - 7
EP - 8
JO - Topics in antiviral medicine
JF - Topics in antiviral medicine
SN - 2161-5853
IS - 1
ER -